Meet the labs of the Yale Cancer Biology Institute
-
Alarcón Lab
Uncovering the physiological and pathophysiological roles of RNA modifications at the molecular, cellular, and organism level through multidisciplinary approaches
-
Ferguson Lab
Defining therapeutic opportunities with growth factor receptors using structure
-
Kabeche Lab
Understanding the interplay between chromosomal instability and DNA damage response defects in cancers to uncover new cancer therapy targets
-
Klein Lab
Deciphering the structural underpinnings of oncogene activation to inform the rational design of antibody therapeutics
-
LaMarche Lab
We combine high-dimensional profiling of cancer patient tissues with detailed mechanistic studies in mouse models to develop new immunotherapies for solid tumors
-
Lemmon Lab
Understanding receptor tyrosine kinase signaling and how to correct aberrant activity when altered in diseases such as cancer
-
Liu Lab
Studying proteomics, protein turnover, and post-translational modifications to understand cancer aneuploidy, cellular signaling transduction, and biodiversity
-
Muzumdar Lab
Deciphering how genetic alterations interact with environmental and host factors to drive cancer development
-
Schlessinger Lab
Analyzing the mode of action of growth factor receptors and the intracellular signaling pathways that activated in response to growth factor stimulation
Upcoming Events
-
Summer Happy Hour!
(multi-day event) -
Summer Happy Hour!
(multi-day event)
YCBI News
-
Protein turnover mapping may offer clues for Alzheimer’s, cancer treatment
The lab of Yansheng Liu has uncovered potential targets for treating Alzheimer’s disease and cancer
-
Yale scientists decode chemical transmitter for clues to new cancer therapies
Yale Cancer Biology Institute scientists have redefined the role of a unique chemical receptor, opening the way for new targeted cancer therapies
-
Lilian Kabeche recognized for excellence in research by an Historically Excluded Person
The award is presented to early-career scientists who self-identify as Historically Excluded Persons